Study the relation between thyroiditis markers (Anti-TPO and Anti TG) and autoimmune urticaria.

Q4 Medicine

Revista Bionatura Pub Date : 2023-10-15 DOI:10.21931/rb/css/2023.08.04.13

Riyam A.S. Al-sofy, Talib A. Hussein, Suaad A. Brakhas

{"title":"Study the relation between thyroiditis markers (Anti-TPO and Anti TG) and autoimmune urticaria.","authors":"Riyam A.S. Al-sofy, Talib A. Hussein, Suaad A. Brakhas","doi":"10.21931/rb/css/2023.08.04.13","DOIUrl":null,"url":null,"abstract":"The current study was focused to study Anti-TPO and Anti-TG , in (80) Chronic Urticaria patients were Clinically diagnosed by dermatologists in Specialized Center of Allergy in Baghdad/Al-Rusafa with age ranged between (11-60), as well as a control group 40 with age ranged between (11-60) from November 2021 to April 2022, The results of demographic and clinical characteristics revealed the rate of female patients was higher than male56.3%, 43.8% respectively, The results showed there was highly significant difference between the patients and the control in Anti-Tpo also the results showed Anti-TG were higher than control but no significant differences while the patient with age 21-30 year and 11-20 had highest Anti-Tpo and Anti-TG, the level of Anti-Tpo and Anti- TG between post-treatment and pre-treatment showed various results , Anti-Tpo and Anti- TG in post-treatment was lower than pre-treatment but higher than the control group significant difference between those group at p ≤ 0.05 The results showed Finally The ROC showed the Anti-Tpo and Anti- TG were discriminated as accurate biomarkers for CSU. Keywords: Anti-Tpo, Anti-TG, CUS, Age and treatment.","PeriodicalId":52287,"journal":{"name":"Revista Bionatura","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Bionatura","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21931/rb/css/2023.08.04.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

The current study was focused to study Anti-TPO and Anti-TG , in (80) Chronic Urticaria patients were Clinically diagnosed by dermatologists in Specialized Center of Allergy in Baghdad/Al-Rusafa with age ranged between (11-60), as well as a control group 40 with age ranged between (11-60) from November 2021 to April 2022, The results of demographic and clinical characteristics revealed the rate of female patients was higher than male56.3%, 43.8% respectively, The results showed there was highly significant difference between the patients and the control in Anti-Tpo also the results showed Anti-TG were higher than control but no significant differences while the patient with age 21-30 year and 11-20 had highest Anti-Tpo and Anti-TG, the level of Anti-Tpo and Anti- TG between post-treatment and pre-treatment showed various results , Anti-Tpo and Anti- TG in post-treatment was lower than pre-treatment but higher than the control group significant difference between those group at p ≤ 0.05 The results showed Finally The ROC showed the Anti-Tpo and Anti- TG were discriminated as accurate biomarkers for CSU. Keywords: Anti-Tpo, Anti-TG, CUS, Age and treatment.

查看原文本刊更多论文

研究甲状腺炎标志物(抗tpo和抗TG)与自身免疫性荨麻疹的关系。

本研究对2021年11月至2022年4月由巴格达/Al-Rusafa过敏专科中心皮肤科医生临床诊断的80例年龄11-60岁的慢性荨麻疹患者和40例年龄11-60岁的对照组进行了抗tpo和抗tg的研究，人口统计学和临床特征结果显示，女性患者的比例高于男性，分别为56.3%和43.8%。结果显示，患者抗tpo和抗TG均高于对照组，但无显著性差异，其中21 ~ 30岁和11 ~ 20岁患者抗tpo和抗TG最高，治疗前后抗tpo和抗TG水平差异较大。治疗后的Anti- tpo和Anti- TG低于治疗前，但高于对照组，差异有统计学意义(p≤0.05)。结果显示:最终，ROC显示Anti- tpo和Anti- TG被区分为CSU的准确生物标志物。关键词:抗tpo，抗tg, CUS，年龄与治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊